Loading...

Protagonist Therapeutics, Inc.

PTGX•NASDAQ
Healthcare
Biotechnology
$55.15
$1.41(2.62%)

Protagonist Therapeutics, Inc. (PTGX) Stock Chart & Performance Analysis

Explore Protagonist Therapeutics, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-3.95%
5-Day Change
-9.31%
1-Month Change
-26.92%
3-Month Change
11.69%
6-Month Change
-6.19%
Year-to-Date (YTD) Change
4.90%
1-Year Change
46.66%
3-Year Change
69.95%
5-Year Change
485.82%
All-Time (Max) Change
249.49%

Analyzing Protagonist Therapeutics, Inc. (PTGX) Trends Across Multiple Time Frames

Protagonist Therapeutics, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Protagonist Therapeutics, Inc. stock shows -3.95% 1-day change, indicating low volatility, while its 5-day change of -9.31% suggests a broader trend. Over a 1-month period, a -26.92% drop could signal a pullback, whereas a 3-month rise of 11.69% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -6.19% and a YTD rise of 4.90% might concern investors, but a 1-year gain of 46.66% and a 3-year increase of 69.95% could indicate resilience. The 5-year surge of 485.82% highlights strong historical growth, while the all-time return of 249.49% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;